Russell Investments Group
ELDN icon

Russell Investments Group’s Eledon Pharmaceuticals ELDN Stock Holding History

Russell Investments Group’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161K Buy
40,923
+35,628
+673% +$130K ﹤0.01% 3262
2026
Q1 		$16.3K Sell
5,295
-5,486
-51% -$12.9K ﹤0.01% 3673
2025
Q4 		$16.3K Buy
10,781
+5,927
+122% +$14.1K ﹤0.01% 3684
2025
Q3 		$12.6K Buy
+4,854
New +$14.2K ﹤0.01% 3730

Other funds holding ELDN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
PAM
Prodigy Asset Management Omaha, Nebraska $332M AUM 10.57% 1-Year Est. Return

Russell Investments Group's ELDN Position: Q2 2026 in Review

Russell Investments Group increased its Eledon Pharmaceuticals (ELDN) stake by 673% in Q2 2026, buying an estimated $130K and bringing the position to 40,923 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #3262.

Russell Investments Group first reported a position in ELDN in Q3 2025 and has held it in 4 quarters since. 77 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Russell Investments Group held 40,923 shares of Eledon Pharmaceuticals worth $161K as of Q2 2026.
  • Russell Investments Group bought 35,628 Eledon Pharmaceuticals shares in Q2 2026, an estimated $130K.
  • Eledon Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3262 holding.
  • Russell Investments Group first reported a position in Eledon Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 77 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.